Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Cohen & Co Inc (COHN)
AMEXFinancialsFinancial - Capital MarketsSnapshot 2026-11-04
$10.00-2.25%
Close 2026-11-05 · 1-day change
AMEXFinancialsFinancial - Capital MarketsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.85 → 1.85 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for COHN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Cash flow from operations to improve from negative levels | The company is working to improve profit and cash flow. | Improving | cash flow stays below -$5M | Cash from operations: $3.922M FY2026-Q2; GAAP. Published target: cash flow from operations >= -$5M next 4 quarters. Target period is not explicitly aligned with this observation. Aug 3, 20263,922,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk financials business with growth tied to investment banking and SPAC activity, rather than a clearly durable compounder. The multi-year view is on watch: recent revenue progress is encouraging, but financial performance remains weak versus its industry cohort and earnings quality is fragile.
COHN is described as cheap versus peers, while the model’s expectations gap is negative, suggesting expectations are subdued. The evidence labels pricing as justified and fragility as low, but confidence is medium, so the valuation signal is not conclusive.
Near term, management’s revenue priority is on track: revenue rose across the cited quarters, and investment banking revenue also increased from 2026-Q1 to 2026-Q2. The quarterly dividend was maintained through 2026-Q2, though management reviews its policy each quarter; a guidance cut, recent weak performance, and the history of a deep miss remain risks.
The multi-year thesis depends on continued revenue growth from investment banking and SPAC activity, including frontier technologies, without a deterioration in guidance. Near term, rate cuts could weigh on financials, while continued strong earnings and higher guidance from sector bellwethers could support sector momentum; the available evidence gives limited detail on COHN’s own forward results.
For the next one to three years, COHN has meaningful growth evidence but also fragile earnings quality, high risk, and weak relative performance. The thesis remains on watch, with execution and sector conditions as key swing factors. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Cohen & Co Inc's published investment case. The stated target is operating income >= $20M next 4 quarters. |
| Improving |
| operating income stays below $20M |
Operating income: $12.409M FY2026-Q2; GAAP. Published target: operating income >= $20M next 4 quarters. Target period is not explicitly aligned with this observation. Aug 3, 202612,409,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “The gestation repo book of business was $4.1 billion at June 30, 2026.” “The gestation repo book of business was $3.9 billion at March 31, 2026.” Operating income was $12.409 million in 2026-Q2. Delivery assessment Nov 4, 2026 |
Revenue growth to sustain above $100M quarterly | A primary condition in Cohen & Co Inc's published investment case. The stated target is >= $100M quarterly revenue. | Broken | quarterly revenue falls below $100M | Revenue: $69.487M FY2026-Q2; GAAP. Published target: >= $100M quarterly revenue. Target period is not explicitly aligned with this observation. Aug 3, 202669,487,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Cohen & Company Capital Markets (“CCM”), a division of Cohen & Company Securities, LLC, generated substantially all of the investment banking and new issue revenue in the three quarters presented.” “Cohen & Company Capital Markets (“CCM”) generated $45.7 million, $50.8 million, and $20.2 million of the investment banking and new issue revenue in 1Q26, 4Q25, and 1Q25, respectively.” Revenue was $69.487 million in 2026-Q2. Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.85 → $1.85 · observed estimates
$180.81B → $0.18B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.85 | $180,815,000,000 | 1 / 1 |
| 2026-07-25 | $1.85 | $180,815,000,000 | 1 / 1 |
| 2026-07-26 | $1.85 | $180,815,000,000 | 1 / 1 |
| 2026-07-27 | $1.85 | $180,815,000,000 | 1 / 1 |
| 2026-07-28 | $1.85 | $180,815,000,000 | 1 / 1 |
| 2026-07-29 | $1.85 | $180,815,000,000 | 1 / 1 |
| 2026-07-30 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-07-31 | $1.85 | $180,815,000 | 1 / 1 |
| 2026-08-01 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-02 | $1.85 | $180,815,000 | 1 / 1 |
| 2026-08-03 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-04 | $1.85 | $180,815,000 | 1 / 1 |
| 2026-08-05 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-06 | $1.85 | $180,815,000 | 1 / 1 |
| 2026-08-07 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-08 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-09 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-10 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-11 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-12 | $1.85 | $180,815,000 | 1 / 1 |
| 2026-08-13 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-14 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-15 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-16 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-17 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-18 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-19 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-20 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-21 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-22 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-23 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-24 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-25 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-26 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-27 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-28 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-29 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-30 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-08-31 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-01 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-02 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-03 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-04 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-05 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-06 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-07 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-08 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-09 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-10 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-11 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-12 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-13 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-14 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-15 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-16 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-17 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-18 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-19 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-20 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-21 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-22 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-23 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-24 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-25 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-26 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-27 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-28 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-29 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-09-30 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-01 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-02 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-03 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-04 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-05 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-06 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-07 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-08 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-09 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-10 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-11 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-12 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-13 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-14 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-15 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-16 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-17 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-18 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-19 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-20 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-21 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-22 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-23 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-24 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-25 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-26 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-27 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-28 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-29 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-30 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-10-31 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-11-01 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-11-02 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-11-03 | $1.85 | $180,800,000 | 1 / 1 |
| 2026-11-04 | $1.85 | $180,800,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.